CSN1S1
gene geneOn this page
Summary
CSN1S1 (casein alpha s1, HGNC:2445) is a protein-coding gene on chromosome 4q13.3, encoding Alpha-S1-casein (P47710). Important role in the capacity of milk to transport calcium phosphate.
Predicted to be involved in several processes, including response to 11-deoxycorticosterone; response to dehydroepiandrosterone; and response to progesterone. Located in extracellular space.
Source: NCBI Gene 1446 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 27 total
- MANE Select transcript:
NM_001890
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:2445 |
| Approved symbol | CSN1S1 |
| Name | casein alpha s1 |
| Location | 4q13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000126545 |
| Ensembl biotype | protein_coding |
| OMIM | 115450 |
| Entrez | 1446 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 8 protein_coding
ENST00000246891, ENST00000505782, ENST00000507763, ENST00000507772, ENST00000510936, ENST00000633258, ENST00000949200, ENST00000949201
RefSeq mRNA: 2 — MANE Select: NM_001890
NM_001025104, NM_001890
CCDS: CCDS47067, CCDS54769
Canonical transcript exons
ENST00000246891 — 16 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000865211 | 69942536 | 69942577 |
| ENSE00001024535 | 69940021 | 69940044 |
| ENSE00001024555 | 69932544 | 69932606 |
| ENSE00001024558 | 69931068 | 69931117 |
| ENSE00001024559 | 69934212 | 69934244 |
| ENSE00001024561 | 69937800 | 69937823 |
| ENSE00001024562 | 69937121 | 69937144 |
| ENSE00001024564 | 69939176 | 69939208 |
| ENSE00001171278 | 69936566 | 69936607 |
| ENSE00001171285 | 69936456 | 69936479 |
| ENSE00001171292 | 69935926 | 69935949 |
| ENSE00001171300 | 69934690 | 69934710 |
| ENSE00001705551 | 69946196 | 69946574 |
| ENSE00002454219 | 69942046 | 69942063 |
| ENSE00002700741 | 69944850 | 69945004 |
| ENSE00003788570 | 69941019 | 69941060 |
Expression profiles
Bgee: expression breadth ubiquitous, 124 present calls, max score 89.45.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1124 / max 47.6216, expressed in 13 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 47845 | 0.1124 | 13 |
Top tissues by expression
276 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.45 | gold quality |
| parotid gland | UBERON:0001831 | 76.26 | silver quality |
| layer of synovial tissue | UBERON:0007616 | 74.45 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 71.67 | gold quality |
| synovial joint | UBERON:0002217 | 68.96 | gold quality |
| adipose tissue | UBERON:0001013 | 68.45 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 67.07 | gold quality |
| connective tissue | UBERON:0002384 | 66.83 | gold quality |
| skin of hip | UBERON:0001554 | 66.39 | silver quality |
| thoracic mammary gland | UBERON:0005200 | 61.63 | gold quality |
| mammary gland | UBERON:0001911 | 61.56 | gold quality |
| cingulate cortex | UBERON:0003027 | 60.86 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 60.53 | gold quality |
| diaphragm | UBERON:0001103 | 58.41 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 58.23 | gold quality |
| epithelium of mammary gland | UBERON:0003244 | 57.91 | silver quality |
| mammary duct | UBERON:0001765 | 57.61 | silver quality |
| omental fat pad | UBERON:0010414 | 56.89 | gold quality |
| peritoneum | UBERON:0002358 | 56.84 | gold quality |
| amniotic fluid | UBERON:0000173 | 56.59 | silver quality |
| endometrium epithelium | UBERON:0004811 | 53.13 | gold quality |
| pancreatic ductal cell | CL:0002079 | 53.05 | silver quality |
| mucosa of transverse colon | UBERON:0004991 | 52.06 | gold quality |
| lower lobe of lung | UBERON:0008949 | 51.94 | silver quality |
| vermiform appendix | UBERON:0001154 | 51.28 | gold quality |
| mucosa of urinary bladder | UBERON:0001259 | 51.28 | gold quality |
| frontal pole | UBERON:0002795 | 50.41 | gold quality |
| quadriceps femoris | UBERON:0001377 | 50.30 | gold quality |
| middle frontal gyrus | UBERON:0002702 | 50.30 | gold quality |
| paraflocculus | UBERON:0005351 | 50.18 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-10885 | yes | 54899.83 |
| E-MTAB-10855 | yes | 52657.44 |
| E-MTAB-9841 | yes | 47918.63 |
| E-ANND-3 | yes | 4.39 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): CEBPG, DNMT1, FOXC1, JUN, STAT5A, STAT5B
miRNA regulators (miRDB)
28 targeting CSN1S1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
| HSA-MIR-1323 | 99.83 | 69.89 | 2471 |
| HSA-MIR-4799-5P | 99.82 | 70.60 | 2663 |
| HSA-MIR-548O-3P | 99.74 | 69.30 | 2228 |
| HSA-MIR-26A-1-3P | 99.64 | 66.81 | 788 |
| HSA-MIR-26A-2-3P | 99.64 | 66.82 | 786 |
| HSA-MIR-3128 | 99.50 | 67.85 | 1258 |
| HSA-MIR-32-3P | 99.36 | 68.20 | 2517 |
| HSA-MIR-888-5P | 99.30 | 70.15 | 1855 |
| HSA-MIR-4426 | 99.17 | 66.74 | 1949 |
| HSA-MIR-4784 | 99.15 | 67.41 | 1733 |
| HSA-MIR-3146 | 98.85 | 66.77 | 601 |
| HSA-MIR-3150B-3P | 98.81 | 67.21 | 1728 |
| HSA-MIR-4290 | 98.51 | 65.17 | 907 |
| HSA-MIR-4720-3P | 98.50 | 68.88 | 988 |
| HSA-MIR-4662B | 98.33 | 66.37 | 1163 |
| HSA-MIR-4647 | 98.30 | 66.41 | 1139 |
| HSA-MIR-5579-3P | 97.00 | 68.81 | 1111 |
| HSA-MIR-3059-3P | 96.71 | 67.08 | 606 |
| HSA-MIR-3935 | 96.33 | 66.79 | 797 |
| HSA-MIR-2276-5P | 96.27 | 65.85 | 937 |
| HSA-MIR-7848-3P | 95.69 | 65.00 | 363 |
Literature-anchored findings (GeneRIF, showing 4)
- alphas1-Casein may be a potential biomarker for early identification of BPH patients. (PMID:16683014)
- Casein alpha s1 is expressed in human monocytes and stimulates expression of proinflammatory cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) via an immunomodulatory role beyond the nutritional function of CSN1S1 in milk. (PMID:21135174)
- Results suggest that autoimmunity to insulin can occur infrequently via cross-reactivity to food protein alpha casein. (PMID:21361910)
- Serine-71 in alpha-S1 casein is phosphorylated in the breast milk. (PMID:28786558)
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Csn1s1 | ENSMUSG00000070702 |
Protein
Protein identifiers
Alpha-S1-casein — P47710 (reviewed: P47710)
All UniProt accessions (5): P47710, A0A0J9YVR3, D6RF34, E9PDQ1, H0Y8K1
UniProt curated annotations — full annotation on UniProt →
Function. Important role in the capacity of milk to transport calcium phosphate. Casoxin D acts as opioid antagonist and has vasorelaxing activity mediated by bradykinin B1 receptors.
Subunit / interactions. Heteromultimers of alpha-s1 casein and kappa-casein; disulfide-linked.
Subcellular location. Secreted.
Tissue specificity. Mammary gland specific. Secreted in milk.
Post-translational modifications. Not glycosylated.
Miscellaneous. In milk, the alpha s1- and beta-caseins precipitate in presence of calcium (so-called calcium-sensitive caseins). Kappa-casein prevents the precipitation of the other caseins by calcium through the formation of large stable colloidal particles termed micelles.
Similarity. Belongs to the alpha-casein family.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P47710-1 | 1 | yes |
| P47710-2 | 2 | |
| P47710-3 | 3 | |
| P47710-4 | 4 |
RefSeq proteins (2): NP_001020275, NP_001881* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026999 | Alpha-s1_casein | Family |
| IPR031305 | Casein_CS | Conserved_site |
UniProt features (18 total): modified residue 10, splice variant 3, signal peptide 1, chain 1, sequence variant 1, sequence conflict 1, peptide 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P47710-F1 | 62.57 | 0.05 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (10): 89, 90, 91, 31, 33, 41, 71, 85, 86, 88
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-5223345 | Miscellaneous transport and binding events |
| R-HSA-382551 | Transport of small molecules |
MSigDB gene sets: 47 (showing top):
GOBP_RESPONSE_TO_ESTRADIOL, GOBP_RESPONSE_TO_CORTICOSTEROID, chr4q13, GOBP_RESPONSE_TO_KETONE, MCBRYAN_PUBERTAL_BREAST_3_4WK_UP, MODULE_99, GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, OCT1_07, MCBRYAN_PUBERTAL_BREAST_5_6WK_UP, TGANTCA_AP1_C, GOBP_RESPONSE_TO_STEROID_HORMONE, GOBP_RESPONSE_TO_HORMONE, GOBP_RESPONSE_TO_LIPID, GOBP_RESPONSE_TO_PROGESTERONE, GOBP_RESPONSE_TO_MINERALOCORTICOID
GO Biological Process (4): response to estradiol (GO:0032355), response to progesterone (GO:0032570), response to dehydroepiandrosterone (GO:1903494), response to 11-deoxycorticosterone (GO:1903496)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): extracellular region (GO:0005576), obsolete extracellular space (GO:0005615)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Transport of small molecules | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| response to ketone | 3 |
| response to lipid | 2 |
| response to alcohol | 2 |
| response to oxygen-containing compound | 1 |
| response to steroid hormone | 1 |
| response to mineralocorticoid | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
652 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CSN1S1 | CSN2 | P05814 | 999 |
| CSN1S1 | CSN3 | P07498 | 998 |
| CSN1S1 | LALBA | P00709 | 950 |
| CSN1S1 | LTF | P02788 | 664 |
| CSN1S1 | PRL | P01236 | 652 |
| CSN1S1 | ALB | P02768 | 648 |
| CSN1S1 | STAT5A | P42229 | 572 |
| CSN1S1 | BTN1A1 | Q13410 | 544 |
| CSN1S1 | DGAT1 | O75907 | 520 |
| CSN1S1 | STAT5B | P51692 | 518 |
| CSN1S1 | STATH | P02808 | 514 |
| CSN1S1 | PIGR | P01833 | 510 |
| CSN1S1 | TF | P02787 | 498 |
| CSN1S1 | PAEP | P09466 | 497 |
| CSN1S1 | EFS | O43281 | 488 |
IntAct
11 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CSN1S1 | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KIF1C | KIF1B | psi-mi:“MI:2364”(proximity) | 0.480 |
| CSN1S1 | KLK6 | psi-mi:“MI:0570”(protein cleavage) | 0.440 |
| CUL4A | DDX39A | psi-mi:“MI:0914”(association) | 0.350 |
| CSN1S1 | TIMP3 | psi-mi:“MI:0914”(association) | 0.350 |
| CSN1S1 | KLHL15 | psi-mi:“MI:0914”(association) | 0.350 |
| ZFP36L1 | CNOT1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| CSN1S1 | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TOLLIP | CSN1S1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (43): PDE10A (Affinity Capture-MS), B4GALNT4 (Affinity Capture-MS), LTBP1 (Affinity Capture-MS), EMILIN3 (Affinity Capture-MS), KLHL15 (Affinity Capture-MS), HSPA5 (Affinity Capture-MS), TIMP3 (Affinity Capture-MS), ERF (Affinity Capture-MS), BCOR (Affinity Capture-MS), CDKN2AIP (Affinity Capture-MS), FAM120A (Affinity Capture-MS), ETV3 (Affinity Capture-MS), CSN1S1 (Affinity Capture-MS), CSN1S1 (Affinity Capture-MS), CSN1S1 (Affinity Capture-MS)
ESM2 similar proteins: A1E959, A1E960, A1YQ91, A1YQ92, A1YQ93, A1YQ94, B3A0S0, B4H957, B5DRT7, O55189, O62823, P02662, P02665, P02668, P02669, P02670, P04653, P04656, P06796, P11840, P11841, P18626, P19228, P33618, P39035, P39037, P42155, P42156, P42157, P47710, P50420, P50421, P50422, P50423, P50424, P50425, P79139, P82187, P86273, Q003G9
Diamond homologs: O62823, O97943, P02662, P04653, P04656, P09115, P18626, P39035, P47710, P86272, P19228, P02661
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| CSN1S1 | up-regulates | RELA | phosphorylation |
Disease & clinical
Clinical variants and AI predictions
ClinVar
27 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 23 |
| Likely benign | 2 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2020 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:69942575:GTG:G | donor_gain | 1.0000 |
| 4:69944848:A:AG | acceptor_gain | 1.0000 |
| 4:69944848:AGC:A | acceptor_loss | 1.0000 |
| 4:69944849:G:GT | acceptor_gain | 1.0000 |
| 4:69944849:GC:G | acceptor_gain | 1.0000 |
| 4:69944849:GCC:G | acceptor_gain | 1.0000 |
| 4:69944849:GCCT:G | acceptor_gain | 1.0000 |
| 4:69944849:GCCTT:G | acceptor_gain | 1.0000 |
| 4:69945002:GTG:G | donor_gain | 1.0000 |
| 4:69932602:GGCCT:G | donor_gain | 0.9900 |
| 4:69932603:GCCTG:G | donor_gain | 0.9900 |
| 4:69932612:T:G | donor_gain | 0.9900 |
| 4:69934819:A:G | acceptor_gain | 0.9900 |
| 4:69935108:T:G | acceptor_gain | 0.9900 |
| 4:69936478:GG:G | donor_gain | 0.9900 |
| 4:69936479:GG:G | donor_gain | 0.9900 |
| 4:69937798:A:G | acceptor_gain | 0.9900 |
| 4:69939174:A:AG | acceptor_gain | 0.9900 |
| 4:69939175:G:GG | acceptor_gain | 0.9900 |
| 4:69939175:GAA:G | acceptor_gain | 0.9900 |
| 4:69942531:TGCA:T | acceptor_loss | 0.9900 |
| 4:69942532:GCA:G | acceptor_loss | 0.9900 |
| 4:69942533:CA:C | acceptor_loss | 0.9900 |
| 4:69942534:A:AT | acceptor_loss | 0.9900 |
| 4:69942535:G:GA | acceptor_loss | 0.9900 |
| 4:69942570:TCC:T | donor_gain | 0.9900 |
| 4:69944832:AAAT:A | acceptor_gain | 0.9900 |
| 4:69945000:TGGTG:T | donor_gain | 0.9900 |
| 4:69945001:GGTG:G | donor_gain | 0.9900 |
| 4:69945001:GGTGG:G | donor_gain | 0.9900 |
AlphaMissense
1238 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:69932577:T:C | C8R | 0.985 |
| 4:69944895:T:A | W150R | 0.958 |
| 4:69944895:T:C | W150R | 0.958 |
| 4:69932587:C:A | A11D | 0.957 |
| 4:69932593:C:A | A13D | 0.946 |
| 4:69944897:G:C | W150C | 0.934 |
| 4:69944897:G:T | W150C | 0.934 |
| 4:69932599:C:A | A15D | 0.931 |
| 4:69932590:T:A | V12D | 0.918 |
| 4:69945000:T:A | W185R | 0.908 |
| 4:69945000:T:C | W185R | 0.908 |
| 4:69932581:T:A | L9H | 0.907 |
| 4:69932584:T:A | V10E | 0.902 |
| 4:69932596:T:C | L14P | 0.895 |
| 4:69932581:T:C | L9P | 0.894 |
| 4:69932586:G:C | A11P | 0.875 |
| 4:69932569:T:A | I5N | 0.872 |
| 4:69932579:T:G | C8W | 0.864 |
| 4:69932569:T:C | I5T | 0.858 |
| 4:69932581:T:G | L9R | 0.857 |
| 4:69932592:G:C | A13P | 0.847 |
| 4:69932596:T:A | L14H | 0.846 |
| 4:69944937:T:C | F164L | 0.842 |
| 4:69944939:T:A | F164L | 0.842 |
| 4:69944939:T:G | F164L | 0.842 |
| 4:69932598:G:C | A15P | 0.835 |
| 4:69932578:G:A | C8Y | 0.832 |
| 4:69944928:T:C | F161L | 0.830 |
| 4:69944930:C:A | F161L | 0.830 |
| 4:69944930:C:G | F161L | 0.830 |
dbSNP variants (sampled 300 via entrez): RS1000188149 (4:69931453 A>G), RS1000240586 (4:69931181 G>C,T), RS10002549 (4:69945254 G>A), RS1000382011 (4:69937313 A>C), RS1000525768 (4:69930186 A>G), RS1000582937 (4:69929907 C>A), RS1000692304 (4:69935698 A>G), RS1000753182 (4:69936933 T>C), RS1000831959 (4:69941862 G>A), RS10009308 (4:69930020 C>T), RS10011226 (4:69935723 C>A,T), RS1001322307 (4:69931047 C>T), RS1001371204 (4:69930758 T>C), RS1001681043 (4:69943134 G>A), RS1001862993 (4:69935418 C>T)
Disease associations
OMIM: gene MIM:115450 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | increases expression | 1 |
| zomepirac glucuronide | affects binding | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects cotreatment, increases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| bisphenol S | decreases methylation, affects cotreatment | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Azacitidine | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Lipopolysaccharides | affects cotreatment, increases expression | 1 |
| Nickel | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Sodium Selenite | decreases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.